Ledger.Open graph →
SEC Form D · Amendment · filed September 15, 2014

TISSUE REGENERATION SYSTEMS INC

Offering
$3.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Seattle, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Rona Segev · Tel Aviv, L3DirectorEitan Bek · Tel Aviv, L3Exec · DirectorTLV GP Partners, L.P · Tel Aviv, L3ExecJohn A. Shimp · Charlotte, NCExec · DirectorRobert L. Edwards, Jr · Charlotte, NCDirectorEdward A. Balogh, Jr · Charlotte, NCExec · DirectorGeorge E. Morgan, Iii · Dallas, TXDirectorScott R. Poole · Charlotte, NCDirectorJohn T. Hain · Charlotte, NCDirectorJohn J. Purcell · Charlotte, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗